Routine genetic testing used to guide chemotherapy has been strengthened by including an extra gene variant linked to African ancestry – an update that could potentially help save the lives of Black and ethnic minority cancer patients.
Until last year, in the UK, genetic tests were carried out which only sought to identify four main DPYD varia...